MALIGNANT HEMATOLOGIC DISEASE
Clinical trials for MALIGNANT HEMATOLOGIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT HEMATOLOGIC DISEASE trials appear
Sign up with your email to follow new studies for MALIGNANT HEMATOLOGIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tailored drug dosing may cut infections after stem cell transplants
Disease control Recruiting nowThis study tests whether giving anti-thymocyte globulin (ATG) based on individual patient levels can reduce viral infections after stem cell transplants from unrelated donors. About 324 patients will receive either personalized or fixed doses of ATG. The goal is to find a dose th…
Matched conditions: MALIGNANT HEMATOLOGIC DISEASE
Phase: PHASE4 • Sponsor: Daihong Liu • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple blood test make a key transplant drug safer?
Knowledge-focused Recruiting nowThis study collects blood samples from children and adults receiving the chemotherapy drug busulfan before a stem cell transplant. The goal is to compare a new, faster test with standard lab methods for measuring drug levels in the blood. If the new test works well, it could help…
Matched conditions: MALIGNANT HEMATOLOGIC DISEASE
Sponsor: Saladax Biomedical, Inc. • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC